经导管主动脉瓣退变:临床与转化视角综述
随着TAVI向年轻低危患者拓展,瓣膜长期耐久性备受关注。本综述从基础与转化科学到临床全面梳理TAVI瓣膜BVD的多因素机制,强调多模态影像在检测、分类和监测中的核心作用,并讨论药物与工程创新及再干预策略。
要点
- BVD是多因素过程,包括钙化/非钙化结构 deterioration、非结构 deterioration、瓣膜血栓及操作/器械因素。
- 多模态影像在BVD检测、分类和监测中起关键作用。
- 再干预策略包括再次TAVI和外科取出,CT规划与台架试验有助于优化管理。
核心结论
- 支持对经导管主动脉瓣退变采取主动、个体化的全生命周期管理策略。
研究设计与样本
- 综述类文章,检索范围未在摘要中明确报告。
主要发现
- BVD涵盖钙化与非钙化结构 deterioration、非结构 deterioration、瓣膜血栓及操作或器械相关因素。
- 多模态影像在BVD检测、分类和监测中具有关键作用。
- 药物与工程创新正致力于预防BVD,再干预策略包括再次TAVI和外科取出。
临床怎么用
- 临床应重视多模态影像对TAVI瓣膜退变的检测、分类和监测。
- 再干预决策可借助CT规划与台架试验见解进行个体化制定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
As transcatheter aortic valve implantation (TAVI) is increasingly used in younger and lower-risk patients, long-term valve durability has become a growing concern. Bioprosthetic valve degeneration (BVD) is multifactorial, encompassing calcific and non-calcific structural deterioration, non-structural deterioration, valve thrombosis and procedural or device-related factors. This review aims to provide a look across the spectrum of understanding BVD, presenting insights from fundamental and translational science through to the clinic to give a comprehensive overview of the mechanisms underlying BVD in TAVI valves. This review highlights the pivotal role of multimodality imaging in detection, classification and monitoring of degeneration and discusses the emerging pharmacological and engineering innovations aimed at preventing degeneration. Finally, reintervention strategies, including redo-TAV and surgical explantation, are explored with an emphasis on CT-based planning and bench-testing insights that have enhanced our understanding of BVD and inform ongoing procedural refinement. These perspectives support a proactive and tailored approach to managing transcatheter aortic valve degeneration across the patient's lifetime.
引用
- Yoon J, Liabot Q, Jamieson C, et al. Transcatheter aortic valve degeneration: a combined clinical and translational perspective. Heart. 2026. PMID: 41554635. doi:10.1136/heartjnl-2025-326405
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。